Augustine Therapeutics
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases.
$85M Series A ·
Led by Jeito Capital · Source: fundraisingfox.com
Total raised: $103.17M across 2 sourced rounds
All 2 rounds ↓Signals
About Augustine Therapeutics
Discover our pipeline poised for clinical impact.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $85M | fundraisingfox.com | ||
| Series A | $18.17M | fundraisingfox.com |
Timeline
- Website created
Founders and team
BD
Bart De Strooper FounderJD
Joris De Wit FounderLV
Ludo Van Den Bosch Scientific founder and Chairman of the Advisory Boardsource: augustinetx.com- LVLudo Van den Bosh Founder
SC
Sylvain Celanire Chief Executive Officer
Investors
AAdBio partners
AAsabys Partnerslead investor
CCMT Research Foundation
EEli Lilly
GGemma Frisius Fund
JJeito Capitallead investor
NNewton Biocapital
NNovo Holdingslead investor
PPMV
VV-Bio Ventures
VVIB
Companies like Augustine Therapeutics
AAtavistik Bio$40M Series B+ · Mar 2026
GGesynta PharmaSeries B+ · Jul 2025
SSynthekine$100M Series B+ · Jan 2023
SStorm Therapeutics$56M Series B+ · Apr 2026
OOligomerix$2.7M Series B+ · Jun 2022CClaris Bio$118M Series B+ · Jul 2026
Other companies backed by Jeito Capital
BBionyra$165M Series A · Jun 2026
AAzafaros$150M Series B+ · May 2025
CCatalYm$150M Series B+ · Jul 2024
HHI-Bio$95M Series B+ · Jan 2024
NNMD Pharma$80M Series B+ · Nov 2023
PPulmocide$52M Series B+ · Dec 2022
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/augustine-therapeutics (get a free API key).